Literature DB >> 21406342

Simultaneous spectrophotometric determination of valsartan and hydrochlorothiazide by H-point standard addition method and partial least squares regression.

Karunanidhi Santhana Lakshmi1, Sivasubramanian Lakshmi.   

Abstract

Simultaneous determination of valsartan and hydrochlorothiazide by the H-point standard additions method (HPSAM) and partial least squares (PLS) calibration is described. Absorbances at a pair of wavelengths, 216 and 228 nm, were monitored with the addition of standard solutions of valsartan. Results of applying HPSAM showed that valsartan and hydrochlorothiazide can be determined simultaneously at concentration ratios varying from 20:1 to 1:15 in a mixed sample. The proposed PLS method does not require chemical separation and spectral graphical procedures for quantitative resolution of mixtures containing the titled compounds. The calibration model was based on absorption spectra in the 200-350 nm range for 25 different mixtures of valsartan and hydrochlorothiazide. Calibration matrices contained 0.5-3 μg mL-1 of both valsartan and hydrochlorothiazide. The standard error of prediction (SEP) for valsartan and hydrochlorothiazide was 0.020 and 0.038 μg mL-1, respectively. Both proposed methods were successfully applied to the determination of valsartan and hydrochlorothiazide in several synthetic and real matrix samples.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406342     DOI: 10.2478/v10007-011-0007-5

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  2 in total

1.  Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasma.

Authors:  Mahmoud M Sebaiy; Sobhy M El-Adl; Mohamed M Baraka; Amira A Hassan; Heba M El-Sayed
Journal:  BMC Chem       Date:  2022-09-20

2.  Simultaneous determination of lovastatin and niacin in tablet by first and third derivative spectrophotometry and H-point standard addition methods.

Authors:  M Kazemipour; M Ansari; H Ramezani; M Moradalizadeh
Journal:  Res Pharm Sci       Date:  2012-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.